The love fest between pharmaceuticals and President-elect Obama didn’t last long. They’re planning a national television campaign to educate the public about the risks of letting the government negotiate Medicare drug prices, which stands to cost the industry $30 billion in revenue.
Although spokespeople say that “PhRMA would run exactly the same ad campaign if John McCain had won last week’s presidential election,” I find that highly dubious.
Big Pharma’s has made its opening move in the long chess match of reform. Let’s see the response.
Related posts:
- McCain’s Medicare vote comes back to haunt him
- The candidates on tort reform
- Why health reform is failing
- John McCain so gets it
- Pete Stark regrets his law
- Presidential nominee health secrecy
- The left, right, and health care reform poetry
KevinMD.com on Facebook
{ 1 comment }
It doesn’t seem fair that Pharma would escape the price fixing that hospitals and physicians endure–but then three wrongs don’t make a right. Price fixing causes shortages and there is no value to having pharmaceutical shortages to match the bed and primary care shortages.
Comments on this entry are closed.